CD274 and squamous cell carcinoma: Additionally, most patients had been diagnosed with non-squamous cell carcinoma (69/74, 93.2%), and 63.5% were PD-L1 positive (PD-L1 ≥ 50%, 26/74, 35.1%; 1–49%, 21/74, 28.4%).